| Literature DB >> 30943679 |
Shou-Yu Chu1, Ji-Hyun Jung1, Mi-Jung Park1, Shin-Hye Kim1.
Abstract
PURPOSE: This study was conducted to investigate the distributions of the triglyceride (TG) to high-density lipoprotein-cholesterol (HDL-C) ratio and total cholesterol (TC) to HDL-C ratio, and to explore their usefulness as markers of metabolic syndrome (MetS) in Korean adolescents.Entities:
Keywords: Cholesterol; Dyslipidemia; High-density lipoprotein; Metabolic syndrome; Obesity; Triglycerides; Adolescents
Year: 2019 PMID: 30943679 PMCID: PMC6449623 DOI: 10.6065/apem.2019.24.1.41
Source DB: PubMed Journal: Ann Pediatr Endocrinol Metab ISSN: 2287-1012
Subject general characteristics
| Characteristic | Total (n=2,721) | Boys (n=1,436) | Girls (n=1,285) | |
|---|---|---|---|---|
| Age (yr) | 14.1±0.1 | 14.1±0.1 | 14.1±0.1 | 0.988 |
| 10–12 | 1,015 (37.3) | 558 (38.9) | 457 (35.6) | 0.143 |
| 13–15 | 975 (35.8) | 493 (34.3) | 482 (37.5) | |
| 16–18 | 731 (26.9) | 385 (26.8) | 346 (26.9) | |
| Weight (kg) | 54.1±0.3 | 57.7±0.5 | 50.0±0.4 | <0.001 |
| WC (cm) | 69.4±0.2 | 71.7±0.3 | 66.8±0.3 | <0.001 |
| BMI (kg/m2) | 20.6±0.1 | 21.0±0.1 | 20.1±0.1 | <0.001 |
| BMI status | ||||
| Underweight | 157 (5.8) | 78 (5.4) | 79 (6.1) | 0.11 |
| Normal weight | 2,040 (75) | 1,058 (77.7) | 982 (76.4) | |
| Overweight | 353 (13) | 206 (14.3) | 147 (11.4) | |
| Obese | 171 (6.3) | 94 (6.5) | 77 (6.0) | |
| Total cholesterol (mg/dL) | 156.6±0.7 | 152.5±1.0 | 159.9±0.8 | <0.001 |
| Triglycerides (mg/dL) | 76.1±1.0 | 74.9±1.0 | 77.9±1.0 | 0.066 |
| HDL-C (mg/dL) | 48.8±0.2 | 47.6±0.3 | 50.5±0.3 | <0.001 |
| LDL-C (mg/dL) | 89.7±0.6 | 85.8±0.9 | 91.0±0.7 | < 0.001 |
| Non-HDL-C (mg/dL) | 106.2±0.1 | 103.2±0.9 | 108.4±0.8 | <0.001 |
| TC/HDL-C ratio | 3.2±0.1 | 3.2±0.1 | 3.2±0.1 | 0.872 |
| TG/HDL-C ratio | 1.6±0.1 | 1.6±0.1 | 1.6±0.1 | 0.908 |
| Glucose (mg/dL) | 89.2±0.1 | 89.8±0.2 | 88.6±0.2 | <0.001 |
| Insulin (μIU/mL) | 13.4±0.1 | 13.2±0.2 | 13.8±0.2 | 0.009 |
| HOMA-IR | 3.0±0.1 | 2.9±0.1 | 3.0±0.1 | 0.12 |
| Central obesity | 234 (8.1) | 113 (7.2) | 121 (9.0) | 0.164 |
| Hypertriglyceridemia | 250 (9.5) | 134 (10.3) | 116 (8.6) | 0.2 |
| Hypo-HDL-cholesterolemia | 500 (19.0) | 237 (16.4) | 263 (22.0) | 0.002 |
| Hyperglycemia | 140 (5.6) | 79 (6.2) | 61 (4.9) | 0.183 |
| Hypertension | 62 (2.8) | 51 (4.4) | 11 (1.0) | <0.001 |
| Metabolic syndrome | 42 (1.5) | 20 (1.2) | 22 (1.7) | 0.366 |
Values are presented as mean (geometric geometric mean for lipid parameters)±standard error or number (%).
Metabolic syndrome was defined using International Diabetes Federation criteria.
BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment for insulin resistance; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride; WC, waist circumference.
Distributions of lipid profiles by age group
| Variable | Boys | Girls | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Geometric mean (95% CI) | 5th | 10th | 90th | 95th | Geometric mean (95% CI) | 5th | 10th | 90th | 95th | |
| TC (mg/dL) | ||||||||||
| Total | 152.5 (150.6–154.4) | 115 | 124 | 192 | 204 | 159.9 (158.3–161.6) | 124 | 132 | 196 | 207 |
| 10–12 yr | 161.9 (159.2–164.6)[ | 124 | 132 | 198 | 210 | 160.1 (157.7–162.6) | 127 | 133 | 192 | 201 |
| 13–15 yr | 147.9 (145.1–150.8) | 112 | 120 | 181 | 197 | 158.7 (156.1–161.3) | 121 | 129 | 198 | 208 |
| 16–18 yr[ | 148.4 (145.7–151.2) | 110 | 120 | 185 | 197 | 161.1 (158.0–164.3) | 125 | 132 | 200 | 209 |
| Triglycerides (mg/dL) | ||||||||||
| Total | 74.9 (72.2–77.7) | 34 | 39 | 147 | 186 | 77.9 (75.5–80.3) | 37 | 44 | 146 | 174 |
| 10–12 yr | 70.6 (66.7–74.7)[ | 31 | 37 | 142 | 184 | 86.5 (82.4–90.9)[ | 36 | 45 | 152 | 183 |
| 13–15 yr | 75.0 (70.6–79.7) | 34 | 40 | 148 | 197 | 77.8 (73.7–82.1)[ | 38 | 45 | 145 | 181 |
| 16–18 yr[ | 79.0 (74.6–83.7) | 37 | 42 | 152 | 186 | 70.7 (67.5–74.1) | 37 | 41 | 127 | 160 |
| HDL-C (mg/dL) | ||||||||||
| Total | 47.6 (47.1–48.2) | 35 | 37 | 62 | 66 | 50.0 (49.4–50.6) | 36 | 39 | 63 | 67 |
| 10–12 yr | 50.5 (49.5–51.5)[ | 36 | 39 | 65 | 70 | 49.7 (48.8–50.6) | 36 | 39 | 63 | 68 |
| 13–15 yr | 46.4 (45.7–47.2) | 35 | 36 | 59 | 63 | 49.4 (48.3–50.6) | 36 | 39 | 62 | 66 |
| 16–18 yr[ | 46.1 (45.2–47.0) | 34 | 36 | 57 | 63 | 50.9 (49.8–52.0) | 37 | 39 | 64 | 68 |
| LDL-C (mg/dL) | ||||||||||
| Total | 85.8 (84.1–87.5) | 55 | 63 | 119 | 130 | 91.0 (89.5–92.5) | 61 | 68 | 123 | 133 |
| 10–12 yr | 93.3 (91.1–95.6)[ | 60 | 69 | 126 | 138 | 89.4 (87.2–91.7)[ | 57 | 67 | 119 | 128 |
| 13–15 yr | 82.2 (79.9–84.6) | 54 | 60 | 112 | 122 | 90.3 (88.0–92.6) | 61 | 67 | 123 | 134 |
| 16–18 yr[ | 82.5 (79.9–85.2) | 48 | 59 | 117 | 127 | 93.2 (90.6–96.0) | 64 | 69 | 128 | 140 |
| Non-HDL-C (mg/dL) | ||||||||||
| Total | 103.2 (101.4–105.0) | 69 | 77 | 141 | 153 | 108.4 (106.9–110.0) | 76 | 82 | 143 | 156 |
| 10–12 yr | 109.7 (107.3–112.2)[ | 77 | 82 | 148 | 158 | 108.9 (106.6–111.3) | 75 | 84 | 141 | 150 |
| 13–15 yr | 99.8 (96.9–102.7) | 68 | 75 | 135 | 149 | 108.0 (105.6–110.4) | 76 | 81 | 143 | 160 |
| 16–18 yr[ | 100.6 (98.0–103.4) | 65 | 73 | 139 | 154 | 108.6 (105.6–111.6) | 76 | 81 | 147 | 159 |
| TC/HDL-C ratio | ||||||||||
| Total | 3.2 (3.1–3.3) | 2.3 | 2.4 | 4.3 | 4.7 | 3.2 (3.1–3.3) | 2.4 | 2.5 | 4.1 | 4.6 |
| 10–12 yr | 3.2 (3.1–3.3) | 2.3 | 2.4 | 4.2 | 4.5 | 3.2 (3.1–3.3) | 2.3 | 2.5 | 4.2 | 4.6 |
| 13–15 yr | 3.2 (3.1–3.3) | 2.3 | 2.5 | 4.3 | 4.7 | 3.2 (3.1–3.3) | 2.4 | 2.5 | 4 | 4.6 |
| 16–18 yr[ | 3.2 (3.1–3.3) | 2.3 | 2.4 | 4.5 | 5 | 3.2 (3.1–3.3) | 2.4 | 2.5 | 4.3 | 4.7 |
| TG/HDL-C ratio | ||||||||||
| Total | 1.6 (1.5–1.7) | 0.6 | 0.7 | 3.5 | 4.5 | 1.6 (1.5–1.7) | 0.7 | 0.8 | 3.3 | 4.3 |
| 10–12 yr | 1.4 (1.3–1.5)[ | 0.5 | 0.6 | 3.4 | 4.4 | 1.7 (1.6–1.8)[ | 0.6 | 0.8 | 3.5 | 4.6 |
| 13–15 yr | 1.6 (1.5–1.7) | 0.6 | 0.7 | 3.4 | 5.1 | 1.6 (1.5–1.7)[ | 0.7 | 0.8 | 3.2 | 4.3 |
| 16–18 yr[ | 1.7 (1.6–1.8) | 0.7 | 0.9 | 3.8 | 4.5 | 1.4 (1.3–1.5) | 0.6 | 0.7 | 2.9 | 3.7 |
CI, confidence interval; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride.
P<0.05.
P<0.001.
Reference for comparison of geometric mean in age group
Fig. 1.Receive-operating characteristic (ROC) curves of lipid parameters and homeostatic model assessment for insulin resistance (HOMA-IR) for metabolic syndrome. The area under the curve (AUC) values of the TG/HDL-C ratio and TC/HDL-C ratio were higher than those of the other lipid profiles. The AUC value of the TG/HDL-C ratio was higher than that of the TC/HDL-C ratio in boys. In contrast, the AUC value of the TC/HDL-C ratio was higher than that of the TG/HDL-C ratio in girls. TC/HDL-C, total cholesterol to high density lipoprotein cholesterol; TG/HDL-C, triglyceride to high density lipoprotein cholesterol.
AUCROC and cutoff values of HOMA-IR and lipid parameters for prediction of metabolic syndrome
| Variable | TG/HDL-C | TC/HDL-C | TG | HOMA-IR | Non-HDL-C |
|---|---|---|---|---|---|
| Total | |||||
| AUCROC±SE | 0.932±0.014 | 0.923±0.017 | 0.909±0.018 | 0.812±0.037 | 0.788±0.034 |
| Cutoff | 3.3 | 3.8 | 144 | 3.6 | 120 |
| Sensitivity (%) | 85.7 | 92.9 | 81 | 78.6 | 73.8 |
| Specificity (%) | 89.9 | 82.8 | 90.6 | 78.1 | 71.4 |
| Boys | |||||
| AUCROC±SE | 0.934±0.021 | 0.882±0.032 | 0.925±0.025 | 0.808±0.054 | 0.756±0.052 |
| Cutoff | 3.3 | 3.8 | 151 | 3.8 | 110 |
| Sensitivity (%) | 90.0 | 90.0 | 85.0 | 75.0 | 85.0 |
| Specificity (%) | 89.1 | 81.4 | 91.9 | 82.8 | 61.5 |
| Girls | |||||
| AUCROC±SE | 0.932±0.019 | 0.960±0.011 | 0.894±0.026 | 0.815±0.051 | 0.818±0.041 |
| Cutoff | 3.3 | 3.8 | 145 | 3.6 | 138 |
| Sensitivity (%) | 81.8 | 95.5 | 77.3 | 81.8 | 63.0 |
| Specificity (%) | 92.4 | 84.0 | 91.0 | 77.0 | 87.5 |
AUCROC, area under the curve of the receiver operating characteristic; HOMA-IR, homeostatic model assessment for insulin resistance; HDL-C, highdensity lipoprotein cholesterol; SE, standard error; TC/HDL-C, total cholesterol to high density lipoprotein cholesterol; TG/HDL-C, triglyceride to high density lipoprotein cholesterol.
Fig. 2.Prevalence of metabolic syndrome in Korean adolescents with central obesity (n=234; 113 boys,121 girls) in accordance with TG/HDL-C ratio and TC/HDL-C ratio was as follows: 4.4% in those with both lipid ratios below the cutoffs, 30.7% in those with one of the lipid ratios above the respective cutoff, 52.4% for those with both lipid ratios above the cutoffs. Cutoffs of TG/HDL-C and TC/HDL-C were 3.3 and 3.8, respectively. TC/HDL-C, total cholesterol to high density lipoprotein cholesterol; TG/HDL-C, triglyceride to high density lipoprotein cholesterol.
Fig. 3.Adjusted odds ratios for metabolic syndrome (MetS) in adolescents whose lipid ratio values were above the cutoffs (TC/HDL-C ratio≥3.8, TG/HDL-C ratio≥3.3) relative to the adolescents whose lipid ratios were within normal ranges (adjusted for sex, age, and body mass index). The odds ratio (95% confidence interval) for MetS in adolescents with a high TC/HDL-C ratio, high TG/HDL-C ratio, and high TG/HDL-C & TC/HDL-C ratios were 14.8 (2.8–77.4), 30.6 (6.0–157.6), and 36.2 (7.2–186.2), respectively. TC/HDL-C, total cholesterol to high density lipoprotein cholesterol; TG/HDL-C, triglyceride to high density lipoprotein cholesterol.